Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
Parkinson’s disease (PD) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (CNS). To date, there is no cure for the disease, with current pharmacological treatments aimed at controlling the symptoms. Therefore, th...
Main Authors: | Nicola Paccione, Mahdieh Rahmani, Emilia Barcia, Sofía Negro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/13 |
Similar Items
-
Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
by: Yaquelyn Casanova, et al.
Published: (2022-05-01) -
Characterization of Magnetic Polymeric Microparticles
by: Kazım Köse
Published: (2016-08-01) -
Serotonin syndrome induced by anti-parkinsonism drugs:a case report
by: WU Dongdong, LI Shuhua, SU Wen, LIU Yinghong, CHEN Haibo, CHEN Di
Published: (2023-06-01) -
The inhibition of monoamine oxidase by harmine derivatives
by: Theo Myburg, et al.
Published: (2022-01-01) -
Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease
by: Espinoza-Vinces C, et al.
Published: (2023-10-01)